Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, an expert medical oncology panel led by John L. Marshall, MD, with Jamie E. Chaft, MD, and Scot Niglio, MD, provides a brief overview on the revolutionary changes brought by immuno-oncology to the management of gastrointestinal, thoracic, and genitourinary cancers. Then, the panel answers clinician questions on important topics such as:
Content based on an online CME program supported by an educational grant from Merck Sharp & Dohme Corp.
Link to full program: https://www.clinicaloptions.com/oncology/programs/biomarkers2020
Chief, Division of Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York
Senior Scientific Director
Senior Clinical Editor
Associate Director, Scientific Services
Director, CME Program Development
Senior Director, Educational Strategy
This program has been made available online.
From Clinical Care Options (CCO), expert commentary on key new developments in CAR T-cell therapy and a preview of CAR T-cell data at ASH 2020
Download this brief slideset on the rationale for using immunotherapy in the treatment of ES-SCLC, from Clinical Care Options (CCO)
Download this brief slideset for a review of the latest clinical data informing the optimal use of immunotherapy for treatment-naive ES-SCLC, from Clinical Care Options (CCO)
Download this brief slideset on best practices for treating LS-SCLC, from Clinical Care Options (CCO)